PHARMACOLOGY 9T`
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Table of Contents
Table of Contents Chapter 28: Peptides,
Antimalarial, and
Chapter 01: Drug Development and Anthelmintic
Ethical Considerations Chapter 29: HIV- and AIDS-
Chapter 02: Pharmacokinetics, Related Drugs
Pharmacodynamics, and Chapter 30: Transplant
Pharmacogenetics Drugs Chapter 31: Vaccines
Chapter 03: Cultural Considerations Chapter 32: Anticancer
Chapter 04: Complementary and Drugs
Alternative Therapies Chapter 33: Targeted Therapies to
Chapter 05: Pediatric Considerations Treat Cancer
Chapter 06: Geriatric Considerations Chapter 34: Biologic
Chapter 07: Drugs in Substance Use Response Modifiers
Disorder Chapter 35: Upper
Chapter 08: The Nursing Process and Respiratory Disorders
Patient-Centered Care Chapter 36: Lower
Chapter 09: Safety and Quality Respiratory Disorders
Chapter 10: Drug Administration Chapter 37: Cardiac Glycosides,
Chapter 11: Drug Calculations Antianginals, and
Chapter 12: Fluid Volume and Antidysrhythmics Chapter 38:
Electrolytes Diuretics
Chapter 13: Vitamin and Mineral Chapter 39: Antihypertensive
Replacement Chapter 40: Anticoagulants,
Chapter 14: Nutritional Support Antiplatelets, and Thrombolytics
Chapter 15: Adrenergic Agonists and Chapter 41: Antihyperlipidemics
Antagonists and Peripheral Vasodilators
Chapter 16: Cholinergic Agonists and Chapter 42: Gastrointestinal
Antagonists Tract Disorders
Chapter 17: Stimulants Chapter 43: Antiulcer Drugs
Chapter 18: Depressants Chapter 44: Eye and Ear Disorders
Chapter 19: Antiseizure Drugs Chapter 45: Dermatologic
Chapter 20: Drugs for Parkinsonism and Disorders Chapter 46: Pituitary,
Alzheimer's Disease Thyroid, Parathyroid, and Adrenal
Chapter 21: Drugs for Neuromuscular Disorders Chapter 47: Antidiabetics
Disorders and Muscle Spasms Chapter 48: Urinary Disorders
Chapter 22: Antipsychotics and Chapter 49: Pregnancy and
Anxiolytics Preterm Labor
Chapter 23: Antidepressants and Mood Chapter 50: Labor, Delivery,
Stabilizers and Postpartum
Chapter 24: Antiinflammatories Chapter 51: Neonatal and Newborn
Chapter 25: Analgesics Chapter 52: Women's Reproductive
Chapter 26: Antibacterials Health
Chapter 27: Antituberculars, Antifungals, Chapter 53: Men's Reproductive
and Antivirals Health Chapter 54: Sexually
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Transmitted Infections
Chapter 55: Adult and
Pediatric Emergency Drugs
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half
of the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection
box. ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a
generic form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-
proprietary. ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic medication
may be given.The patient asks the nurse what this means. What will the nurse tell the patient
about generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs official
name. The nurse understands that this designation indicates the drug
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Table of Contents
Table of Contents Chapter 28: Peptides,
Antimalarial, and
Chapter 01: Drug Development and Anthelmintic
Ethical Considerations Chapter 29: HIV- and AIDS-
Chapter 02: Pharmacokinetics, Related Drugs
Pharmacodynamics, and Chapter 30: Transplant
Pharmacogenetics Drugs Chapter 31: Vaccines
Chapter 03: Cultural Considerations Chapter 32: Anticancer
Chapter 04: Complementary and Drugs
Alternative Therapies Chapter 33: Targeted Therapies to
Chapter 05: Pediatric Considerations Treat Cancer
Chapter 06: Geriatric Considerations Chapter 34: Biologic
Chapter 07: Drugs in Substance Use Response Modifiers
Disorder Chapter 35: Upper
Chapter 08: The Nursing Process and Respiratory Disorders
Patient-Centered Care Chapter 36: Lower
Chapter 09: Safety and Quality Respiratory Disorders
Chapter 10: Drug Administration Chapter 37: Cardiac Glycosides,
Chapter 11: Drug Calculations Antianginals, and
Chapter 12: Fluid Volume and Antidysrhythmics Chapter 38:
Electrolytes Diuretics
Chapter 13: Vitamin and Mineral Chapter 39: Antihypertensive
Replacement Chapter 40: Anticoagulants,
Chapter 14: Nutritional Support Antiplatelets, and Thrombolytics
Chapter 15: Adrenergic Agonists and Chapter 41: Antihyperlipidemics
Antagonists and Peripheral Vasodilators
Chapter 16: Cholinergic Agonists and Chapter 42: Gastrointestinal
Antagonists Tract Disorders
Chapter 17: Stimulants Chapter 43: Antiulcer Drugs
Chapter 18: Depressants Chapter 44: Eye and Ear Disorders
Chapter 19: Antiseizure Drugs Chapter 45: Dermatologic
Chapter 20: Drugs for Parkinsonism and Disorders Chapter 46: Pituitary,
Alzheimer's Disease Thyroid, Parathyroid, and Adrenal
Chapter 21: Drugs for Neuromuscular Disorders Chapter 47: Antidiabetics
Disorders and Muscle Spasms Chapter 48: Urinary Disorders
Chapter 22: Antipsychotics and Chapter 49: Pregnancy and
Anxiolytics Preterm Labor
Chapter 23: Antidepressants and Mood Chapter 50: Labor, Delivery,
Stabilizers and Postpartum
Chapter 24: Antiinflammatories Chapter 51: Neonatal and Newborn
Chapter 25: Analgesics Chapter 52: Women's Reproductive
Chapter 26: Antibacterials Health
Chapter 27: Antituberculars, Antifungals, Chapter 53: Men's Reproductive
and Antivirals Health Chapter 54: Sexually
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Transmitted Infections
Chapter 55: Adult and
Pediatric Emergency Drugs
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half
of the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection
box. ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a
generic form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-
proprietary. ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic medication
may be given.The patient asks the nurse what this means. What will the nurse tell the patient
about generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs official
name. The nurse understands that this designation indicates the drug
